<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antiphospholipid (aPL) Abs are associated with <z:mp ids='MP_0005048'>thrombosis</z:mp>, pregnancy loss, and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> or <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>beta2-<z:chebi fb="2" ids="17089">Glycoprotein</z:chebi> I (beta2GPI), a <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-binding serum protein, is involved in aPL binding to <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>aPL can be generated in mice by immunization with beta2GPI, and these Abs are thrombogenic and cause pregnancy loss in mice </plain></SENT>
<SENT sid="3" pm="."><plain>The objective of this study is to determine whether aPL induced by immunization with the <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-binding site of beta2GPI are thrombogenic and whether they activate endothelial cells (EC) in vivo and in vitro </plain></SENT>
<SENT sid="4" pm="."><plain>Murine monoclonal aPL were generated from spleen cells of a mouse immunized with GDKV, a synthetic 15-aa <z:chebi fb="7" ids="16670">peptide</z:chebi> spanning Gly274-Cys288 in the fifth domain of human beta2GPI, which represents the <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-binding site of beta2GPI </plain></SENT>
<SENT sid="5" pm="."><plain>The Abs generated had aPL and anti-beta2GPI activities </plain></SENT>
<SENT sid="6" pm="."><plain>The effect of these Abs on <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation and on EC activation in vivo was determined using a mouse model of <z:mp ids='MP_0005048'>thrombosis</z:mp> and microcirculation that enables examination of the <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of leukocyte to EC as an indication of EC activation as well as <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule expression using in vitro ELISA analysis </plain></SENT>
<SENT sid="7" pm="."><plain>Mice injected with this monoclonal aPL showed a significant increase in leukocyte sticking and also produced larger <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> that persisted longer </plain></SENT>
<SENT sid="8" pm="."><plain>Exposure to GDKV-induced aPL for 4 h significantly increased surface Ag expression of E-selectin, ICAM-1, and VCAM-1 </plain></SENT>
<SENT sid="9" pm="."><plain>These data indicate that aPL induced by immunization with the <z:chebi fb="0" ids="16247">phospholipid</z:chebi> binding site of beta2GPI are thrombogenic and activate endothelial cells </plain></SENT>
</text></document>